| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10309073 | Schizophrenia Research | 2013 | 6 Pages |
Abstract
Zonisamide as an adjuvant treatment is tolerated well and markedly affect on the weight loss of patients with schizophrenia being treated with atypical antipsychotics.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Ahmad Ghanizadeh, Mohammad Saeed Nikseresht, Ali Sahraian,